Molecular Imaging Diagnosis of Renal Cancer Using
99mTc-sestamibi SPECT
girentuximab PET-CT
molecular imaging
renal cancer
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
06 Feb 2023
06 Feb 2023
Historique:
received:
06
12
2022
revised:
17
01
2023
accepted:
01
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is under development and will add more value in limiting the postoperative renal function loss and morbidity. We aimed to comprehensively review the research on single photon emission computed tomography/computed tomography (SPECT/CT) and positron emission tomography computed tomography (PET-CT) molecular imaging and to enhance the urologists' and radiologists' knowledge of the current research pattern. We identified an increase in prospective and also retrospective studies that researched to distinguish between benign and malignant lesions and between different clear cell renal cell carcinoma subtypes, with small numbers of patients studied, nonetheless with excellent results on specificity, sensitivity and accuracy, especially for
Identifiants
pubmed: 36832081
pii: diagnostics13040593
doi: 10.3390/diagnostics13040593
pmc: PMC9954934
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Anticancer Res. 2007 Jan-Feb;27(1B):557-62
pubmed: 17348441
J Clin Med. 2020 Jul 13;9(7):
pubmed: 32668651
Urol Oncol. 2020 Dec;38(12):937.e11-937.e17
pubmed: 32859460
Lancet Oncol. 2007 Apr;8(4):304-10
pubmed: 17395103
Theranostics. 2017 Sep 26;7(17):4322-4339
pubmed: 29158829
Can Urol Assoc J. 2021 Jun;15(6):197-201
pubmed: 33212002
J Nucl Med. 2023 Jan;64(1):90-95
pubmed: 35772963
Curr Urol Rep. 2021 Sep 6;22(9):46
pubmed: 34487255
Clin Cancer Res. 1995 Dec;1(12):1611-5
pubmed: 9815963
Eur Urol. 2016 Mar;69(3):413-6
pubmed: 26386607
Eur Urol. 2022 May;81(5):476-488
pubmed: 35216855
J Nucl Med Technol. 2019 Sep;47(3):258-262
pubmed: 31019039
World J Urol. 2022 Jan;40(1):1-8
pubmed: 33492425
Eur J Nucl Med Mol Imaging. 2004 May;31(5):714-9
pubmed: 14985865
J Clin Oncol. 2013 Jan 10;31(2):187-94
pubmed: 23213092
Curr Opin Urol. 2021 May 1;31(3):249-254
pubmed: 33742975
Clin Nucl Med. 2017 Apr;42(4):e188-e193
pubmed: 28114223
Nucl Med Biol. 2021 Jan;92:202-216
pubmed: 32475681
Eur J Nucl Med Mol Imaging. 2014 May;41(5):985-94
pubmed: 24604591
Sci Rep. 2019 Oct 17;9(1):14907
pubmed: 31624303
Urol Oncol. 2016 Jun;34(6):259.e1-8
pubmed: 26947350
EJNMMI Res. 2017 Dec;7(1):29
pubmed: 28357787
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):1990-2012
pubmed: 31273437
J Nucl Med. 2007 Jul;48(7):1084-9
pubmed: 17574983
Urol Clin North Am. 2017 May;44(2):147-154
pubmed: 28411907
Eur Urol Focus. 2021 Jul;7(4):827-834
pubmed: 32115400
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3277-3285
pubmed: 33651116
Ann Nucl Med. 2018 Feb;32(2):87-93
pubmed: 29214562
Cancers (Basel). 2022 Mar 09;14(6):
pubmed: 35326544
Urol Oncol. 2018 Aug;36(8):362.e9-362.e15
pubmed: 29866577
Eur J Nucl Med. 1993 Jan;20(1):20-5
pubmed: 7678396
Cancers (Basel). 2020 May 21;12(5):
pubmed: 32455729
Curr Opin Urol. 2018 Jul;28(4):364-368
pubmed: 29847524
Nucl Med Commun. 2020 Oct;41(10):1081-1088
pubmed: 32732603
Radiology. 2008 Jul;248(1):254-63
pubmed: 18566177
Cancer Cytopathol. 2019 Jun;127(6):358-361
pubmed: 31116493
Clin Nucl Med. 2015 Apr;40(4):309-13
pubmed: 25608174
Eur Radiol. 2021 Feb;31(2):580-590
pubmed: 32851448
Clin Nucl Med. 2020 Oct;45(10):765-770
pubmed: 32701813
Eur Urol. 2022 Oct;82(4):399-410
pubmed: 35346519
Pathology. 2021 Jan;53(1):109-119
pubmed: 33223139
Cent European J Urol. 2021;74(3):334-340
pubmed: 34729222
J Surg Res. 2020 Aug;252:216-221
pubmed: 32289578
Curr Opin Urol. 2018 Mar;28(2):159-165
pubmed: 29319547
BJU Int. 2022 Dec;130(6):748-750
pubmed: 36053273
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4236-4245
pubmed: 34136956
Int J Mol Sci. 2022 Apr 30;23(9):
pubmed: 35563414
Eur J Radiol. 2010 Mar;73(3):461-9
pubmed: 20181453
Urology. 2006 Oct;68(4):737-40
pubmed: 17070344
BJU Int. 2017 Apr;119(4):543-549
pubmed: 27528446
Eur Urol. 2018 Aug;74(2):226-232
pubmed: 29784191
Oncotarget. 2016 Aug 30;7(35):56471-56479
pubmed: 27437764
Radiology. 2001 May;219(2):316-33
pubmed: 11323453
Radiol Clin North Am. 2020 Nov;58(6):1135-1146
pubmed: 33040853
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3593-3595
pubmed: 35362794
BJU Int. 2022 Nov;130 Suppl 3:23-31
pubmed: 35365966
J Urol. 2015 Jan;193(1):30-5
pubmed: 25072182
World J Urol. 2018 Dec;36(12):1913-1926
pubmed: 30123932
Semin Nucl Med. 2014 May;44(3):193-201
pubmed: 24832584
Future Oncol. 2019 Feb;15(5):455-457
pubmed: 30618271
J Clin Oncol. 1997 Apr;15(4):1529-37
pubmed: 9193349
Nucl Med Commun. 2008 Mar;29(3):193-207
pubmed: 18349789
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Cent European J Urol. 2020;73(1):33-38
pubmed: 32395320
Abdom Radiol (NY). 2020 Aug;45(8):2532-2541
pubmed: 32193593
EJNMMI Res. 2017 Oct 2;7(1):80
pubmed: 28971329
Cancers (Basel). 2021 Dec 08;13(24):
pubmed: 34944803
J Nucl Med. 1996 Jun;37(6):938-42
pubmed: 8683315
J Urol. 2003 Dec;170(6 Pt 1):2217-20
pubmed: 14634382
Eur Urol. 2010 Jul;58(1):75-83
pubmed: 20359812
J Nucl Med. 1998 May;39(5):849-56
pubmed: 9591588
Expert Rev Med Devices. 2022 Oct;19(10):739-743
pubmed: 36305463
Surg Pathol Clin. 2018 Sep;11(3):611-631
pubmed: 30190144
J Urol. 2002 Dec;168(6):2395-400
pubmed: 12441925
Int J Cancer. 1986 Oct 15;38(4):489-94
pubmed: 2428759
Biologics. 2012;6:395-407
pubmed: 23204838